v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues:      
Total revenues $ 519,098 $ 924,349 $ 679,008
Cost of revenues:      
Total cost of revenues (473,888) (894,723) (576,827)
Gross profit 45,210 29,626 102,181
Operating expenses:      
Research and development expenses (including related parties amounts of US$63,011, US$107,669 and US$135,334 for the years ended December 31, 2025, 2024 and 2023, respectively) (170,960) (274,801) (368,729)
Selling and marketing expenses (including related parties amounts of US$20,125, US$52,636 and US$40,531 for the years ended December 31, 2025, 2024 and 2023, respectively) (148,261) (322,310) (328,935)
General and administrative expenses (including related parties amounts of US$4,227, US$10,873 and US$13,085 for the years ended December 31, 2025, 2024 and 2023, respectively) (135,850) (227,475) (144,533)
Other operating income 38,463 8,638 4,077
Impairment of long-lived assets (51,800) 0 0
Total operating expenses (468,408) (815,948) (838,120)
Operating loss (423,198) (786,322) (735,939)
Interest expenses (including related parties amounts of US$39,109, US$19,504 and nil for the years ended December 31, 2025, 2024 and 2023, respectively) (63,338) (58,218) (10,200)
Interest income (including related parties amounts of US$20,725, US$13,661 and US$122 for the years ended December 31, 2025, 2024 and 2023, respectively) 28,143 22,289 9,204
Investment income (loss), net 10,740 14,232 (1,162)
Foreign currency exchange gains (losses), net 25,709 (11,664) 42
Changes in fair values of liabilities, excluding impact of instrument-specific credit risk (28,319) (285,423) (10,039)
Loss before income taxes and share of results of equity method investments (450,263) (1,105,106) (748,094)
Income tax expense (15,946) (2,012) (1,113)
Share of results of equity method investments 1,987 (171) (1,048)
Net loss (464,222) (1,107,289) (750,255)
Less: Net loss attributable to noncontrolling interests (2) (2,364) (8,254)
Net loss attributable to ordinary shareholders (464,220) (1,104,925) (742,001)
Accretion of redeemable convertible preferred shares 0 (2,979) (15,121)
Net loss available to ordinary shareholders $ (464,220) $ (1,107,904) $ (757,122)
Loss per ordinary share - Basic [1] $ (0.72) $ (1.72) $ (1.6)
Loss per ordinary share - Diluted [1] $ (0.72) $ (1.72) $ (1.60)
Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share - Basic [1] 648,535,169 645,227,356 474,621,603
Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share - Diluted 648,535,169 645,227,356 474,621,603
Other comprehensive (loss) income:      
Fair value changes of liabilities due to instrument-specific credit risk, net of nil income taxes $ 13,875 $ 13,547 $ (8,650)
Foreign currency translation adjustment, net of nil income taxes (29,222) 16,351 16,210
Total other comprehensive (loss) income (15,347) 29,898 7,560
Total comprehensive loss (479,569) (1,077,391) (742,695)
Less: Total comprehensive loss attributable to noncontrolling interests (2) (2,364) (8,254)
Total comprehensive loss attributable to ordinary shareholders (479,567) (1,075,027) (734,441)
Goods      
Revenues:      
Total revenues 462,802 891,061 660,158
Cost of revenues:      
Total cost of revenues (430,031) (867,061) (564,741)
Service      
Revenues:      
Total revenues 56,296 33,288 18,850
Cost of revenues:      
Total cost of revenues $ (43,857) $ (27,662) $ (12,086)
[1] Shares outstanding for all periods reflect the adjustment for Recapitalization.